Alzheimer's & Dementia

Fat distribution differs in symptom-free dementia mutation carriers

Body scans compared 13 symptom-free mutation carriers with 27 non-carriers and found differences in fat distribution and fat around internal organs.

Our read

Biomarkers
Studied:
Cross-sectional study of symptom-free people, against non-carriers
What changed:
Symptom-free mutation carriers had a lower ratio of trunk fat to hip-and-thigh fat than non-carriers
The catch:
Only 13 carriers and 27 non-carriers had body scans

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

Researchers conducted a cross-sectional observational study of 44 symptom-free people: 16 carried an expansion in the dementia-linked gene C9orf72, and 28 did not. All had brain scans; 13 carriers and 27 non-carriers also had a single whole-body scan measuring fat and lean mass.

Carriers had a lower ratio of trunk fat to hip-and-thigh fat and a smaller area of fat around internal organs than non-carriers. Carriers were on average 11–12 years before expected symptom onset. Total fat and lean mass did not differ between groups. In the pooled analysis of carriers and non-carriers, lower trunk-to-hip-and-thigh fat ratios and lower lean mass were associated with smaller volumes in several brain regions.

Why it matters

The authors interpret the findings as evidence that early changes in genetic frontotemporal dementia and amyotrophic lateral sclerosis extend beyond thinking and movement symptoms to broader body functions.

Caveats

Single body scans cannot establish changes over time or whether brain differences caused body composition differences. This small study excluded people with neurological, cognitive or psychiatric abnormalities, so its findings do not describe symptomatic patients.

Comments

Be the first to comment.